Skip to content

Pulmonary Rehabilitation After Minimal Invasive Surgery in Lung Cancer

Pulmonary Rehabilitation After Minimal Invasive Surgery in Lung Cancer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05136300
Acronym
PROMISE
Enrollment
100
Registered
2021-11-29
Start date
2019-05-01
Completion date
2023-07-01
Last updated
2022-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Surgery

Brief summary

Morbidity in the post-operative phase of pulmonary surgery is characterised by impairment due to pain, dyspnoea and loss of exercise tolerance. We demonstrated previously that rehabilitation after thoracotomy is limited due to pain. Since minimal invasive surgery is the new standard in lung cancer, resulting in a reduction of postoperative pain, we believe there are new possibilities for post-operative integrated multidisciplinary rehabilitation in lung cancer.

Interventions

BEHAVIORALPulmonary rehabilitation

Patients in the intervention group will receive physical therapy, scheduled pain monitoring and coaching by a social worker. The intensity of the rehabilitation training program will be determined separately for each patient by a steepramp and 1-repetition test within 3 weeks post-operative. The intervention group will be trained and educated in 2 sessions of 2 hours per week, for a period of 3 months.

Sponsors

Isala
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

RCT

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients undergoing elective, minimal invasive surgery with intention to cure. 2. Age between 18 and 80 years. 3. ECOG 0 - 2 post-surgery.

Exclusion criteria

1. Patients with chronic pain 2. Previous pulmonary surgery 3. Comorbidity limiting rehabilitation 1. Rheumatoid arthritis 2. Severe ischaemic heart disease or myocardial failure; EF ≤ 35 %. 3. Muscle disease 4. Fibromyalgia 5. Neurologic disorders (Parkinson disease, CVA and lesions of the spinal cord) 6. Psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
Quality of life (SF-36)12 monthseffects of an integrated multidisciplinary rehabilitation program on general quality of life

Secondary

MeasureTime frameDescription
SGRQ12 monthshealth-related quality of life
VAS12 monthspost-operative pain
WHO-PS12 monthsperformance score
6 minute walking distance12 monthsexercise tolerance
international physical activity questionnaire, iPAQ12 monthsphysical activity

Countries

Netherlands

Contacts

Primary ContactLars Dinjens
ldinjens@isala.nl0384244597

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026